Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Canna Companion Launches Nationwide in the USA
  • USA - English


News provided by

Canna Companion Products, Inc.

Jan 30, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Monroe Washington (PRWEB) January 30, 2016 -- Canna Companion Products, Inc. of Monroe Washington is pleased to announce the national retail launch of the world’s premiere line of hemp based health products for pets. The formulas were developed after 15 years of R&D and clinical application by the husband and wife veterinarian team of Dr. Sarah Brandon and Dr. Greg Copas. Drs. Brandon & Copas are considered the world leaders in examining cannabis’ potential as a viable holistic compliment to more traditional forms of veterinary medicine, providing a truly integrative approach to utilizing cannabis in pets’ well-care regimens. Canna Companion products have been available via e-commerce since 2014 and now the Company is reaching into all levels of the pet supplement industry, broadly distributing to retail stores, veterinary hospitals and clinics, and through online vendors.

Canna Companion’s Executive Director Dr. Sarah Brandon states:“We are very pleased to expand our product distribution. The goal has always been to make it available for pets on a national scale and we are excited to be at that point in our development.”

This all natural, non-GMO hemp-based product has been meticulously developed by combining traditional and holistic veterinary medicine and the science of cannabis. Dr. Brandon continues: “Cannabis is one of the most therapeutic plants on earth and I have always found it fascinating that every mammal contains an internal cannabis receptor system, called the endocannibinoid system or ECS. Not only does this system produce its own cannabinoids but those same receptors respond to external sources, such as those found in cannabis. Once activated, the ECS helps maintain healthy neurological, immunological and physiological systems, including those of dogs and cats. When all of these systems are balanced and functioning properly, enhanced health is the result.”

The Company’s Chief Scientific Officer, Dr. Greg Copas states: “One of our goals is educating the public about the possible dangers of using CBD-only and hydrocarbon-extracted products intended for human consumption. We are dealing with significant differences in body size and metabolism. A product which may be appropriate for a 180 pound human could be dangerous to a 70 pound Labrador Retriever. Concerning hydrocarbon extractions, such as butane, trace amounts of residual hydrocarbons in any extract may be acceptable for a human but they can cause serious health issues in animals. When using extracted materials, we ensure a CO2-only extraction process is utilized.”
Canna Companion formulations utilize the whole plant which allows the various phytocannabinoids and terpenoids in cannabis to work in synergy, producing what has been identified as an “entourage effect.” This effect means less product is needed in order to achieve the same health benefits with less risk of adverse effects – just as nature intended.

The Company and its products have received significant support from some heavyweights from the areas of veterinary academia, the pet products industry and the entertainment world.

Professor Peter Cowen of North Carolina State University’s College of Veterinary Medicine and now the Company’s Chief Clinical Epidemiologist and an Advisory Board member commented: “Based on my own experience with my dog, Londun, there is something of extreme value here. I am impressed not only from a therapeutic perspective, but also from a psychological perspective.” Professor Cowen is orchestrating a clincial study at NSCU for the coming year and the Company is looking forward to presenting those findings to the veterinary community and the public at large.

Bill Schiaffino, President of New York based SLA Brands, Inc., a leading consulting firm in the US pet products industry stated: “I feel Canna Companion is now entrenched as the category leader and product concept originator in the consciousness of the pet industry. SLA is proud to be the exclusive North American sales management team representing Canna Companion Products Inc.”

In addition, long time cannabis/hemp proponent and world famous cannabis culture and entertainment icon Tommy Chong is also lending his support to the brand: “The decision to work with Canna Companion was obvious for me. I’ve had pets throughout my entire life, and I still do. If we can do anything to improve their quality of life, I’m all for it.”

The Company's on-line store opens February 1, 2016 with the formulation available in capsules specifically designed for dogs and cats and their varying body weights. New products in the pipeline for the coming year include liquids, flavored chews, an equine formula and gift cards. The products are also covered by two of the world leaders in the pet insurance industry, Trupanion and PetPlan.

For more information please visit: http://www.cannacompanionusa.com
For dealer sales, marketing and media enquiries, please contact: Robert W. Stewart
Toll Free 844-447-4412, Ext. 102/103 - Direct: 604-814-0841
Email: rwstewart(at)cannacompanionusa(dot)com

Veterinary and Pet Product Distributors, please contact Mr. Bill Schiaffino/SLA Brands, Inc.
at: 917-750-4200, Email: bill(at)slabrands(dot)com and Mr. Mike Lasky/SLA Brands, Inc.
at 415-747-1001, Email: mike(at)slabrands(dot)com

Copyright 2016 - Canna Companion Products, Inc. - All Rights Reserved.
Canna Companion Products, Inc. is a wholly owned subsidiary of WFS Pharmagreen Inc.

Robert Stewart, Canna Companion Products, Inc., http://www.cannacompanionusa.com, +1 6048140841, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.